PILOT DOSE ESCALATION TRIAL OF BUDESONIDE IN SURFACTANT IN VENTILATED EXTREMELY LOW GESTATIONAL AGE NEWBORNS

被引：0
|
作者：
McEvoy, C. [1 ]
Wadhawan, R. [2 ]
Hudak, M. [3 ]
Weitkamp, H. [4 ]
Harris, J. [1 ]
Asselin, J. [5 ]
Ballard, P. [5 ]
Ballard, R. [5 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Florida Hosp Children, Orlando, FL USA
[3] Univ Florida, Jacksonville, FL USA
[4] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2019年 / 67卷 / 01期
关键词：
D O I：
10.1136/jim-2018-000939.266
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
267
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [1] Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)
    Cindy T. McEvoy
    Philip L. Ballard
    Robert M. Ward
    Joseph E. Rower
    Rajan Wadhawan
    Mark L. Hudak
    Joern-Hendrik Weitkamp
    Julia Harris
    Jeanette Asselin
    Cheryl Chapin
    Roberta A. Ballard
    Pediatric Research, 2020, 88 : 629 - 636
  • [2] Dose-escalation trial of budesonide in surfactant for prevention of bronchopulmonary dysplasia in extremely low gestational age high-risk newborns (SASSIE)
    McEvoy, Cindy T.
    Ballard, Philip L.
    Ward, Robert M.
    Rower, Joseph E.
    Wadhawan, Rajan
    Hudak, Mark L.
    Weitkamp, Joern-Hendrik
    Harris, Julia
    Asselin, Jeanette
    Chapin, Cheryl
    Ballard, Roberta A.
    PEDIATRIC RESEARCH, 2020, 88 (04) : 629 - 636
  • [3] Surfactant Replacement Therapy in Extremely Low Gestational Age Newborns
    Eibisberger, M.
    Resch, E.
    Resch, B.
    INDIAN PEDIATRICS, 2015, 52 (03) : 227 - 230
  • [4] Surfactant replacement therapy in extremely low gestational age newborns
    M. Eibisberger
    E. Resch
    Bernhard Resch
    Indian Pediatrics, 2015, 52 : 227 - 230
  • [5] Blood metabolomics in infants enrolled in a dose escalation pilot trial of budesonide in surfactant
    Philip L. Ballard
    Dara Torgerson
    Rajan Wadhawan
    Mark L. Hudak
    Joern-Hendrik Weitkamp
    Julia Harris
    Jeanette Asselin
    Cheryl Chapin
    Roberta A. Ballard
    Cindy T. McEvoy
    Pediatric Research, 2021, 90 : 784 - 794
  • [6] Blood metabolomics in infants enrolled in a dose escalation pilot trial of budesonide in surfactant
    Ballard, Philip L.
    Torgerson, Dara
    Wadhawan, Rajan
    Hudak, Mark L.
    Weitkamp, Joern-Hendrik
    Harris, Julia
    Asselin, Jeanette
    Chapin, Cheryl
    Ballard, Roberta A.
    McEvoy, Cindy T.
    PEDIATRIC RESEARCH, 2021, 90 (04) : 784 - 794
  • [7] Characteristics of Extremely Low Gestational Age Newborns Undergoing Tracheotomy A Secondary Analysis of the Trial of Late Surfactant Randomized Clinical Trial
    Wai, Katherine C.
    Keller, Roberta L.
    Lusk, Leslie A.
    Ballard, Roberta A.
    Chan, Dylan K.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2017, 143 (01) : 13 - 19
  • [8] Presumed and definite bacteremia in extremely low gestational age newborns
    Patel, Sonal
    Dammann, Olaf
    Martin, Camilia R.
    Allred, Elizabeth N.
    Leviton, Alan
    ACTA PAEDIATRICA, 2011, 100 (01) : 36 - 41
  • [9] Mediators of fetal inflammation in extremely low gestational age newborns
    Dammann, O
    Phillips, TM
    Allred, EN
    O'Shea, TM
    Paneth, N
    Van Marter, LJ
    Bose, C
    Ehrenkranz, RA
    Bednarek, FJ
    Naples, M
    Leviton, A
    CYTOKINE, 2001, 13 (04) : 234 - 239
  • [10] Booster surfactant therapy beyond the first week of life in ventilated extremely low gestational age neonates.
    Merrill, JD
    Ballard, PL
    Hibbs, AM
    Godinez, RI
    Godinez, MH
    Luan, X
    Ryan, R
    Reynolds, AM
    Hamvas, A
    Spence, K
    Courtney, S
    Posencheg, M
    Ades, A
    Lisby, D
    Ballard, RA
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S108 - S108
12345